Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.
Tara Spires-Jones, DPhil, FMedSci, discusses how oligomeric tau clumps inside brain synapses, pointing to indirect evidence that it may be progressing through the brain by jumping between connections.
The co-founder, chief science officer, and chairman at Longeveron discusses the findings from the phase 2a trial CLEARMIND, as well as next steps to developing the therapy Lomecel-B.
Tune into this episode of “Public Health Matters” to hear a discussion with Dr. Frank North centered around successful mentorship and advocacy for representation across minority groups in the pharmacy profession.
Tune into this episode of “Public Health Matters” to hear a discussion with Dr. Frank North centered around successful mentorship and advocacy for representation across minority groups in the pharmacy profession.
Joshua Hare describes how Lomecel-B addresses neuroinflammation, unlike other treatments which typically target amyloid disposition.
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, provides key takeaways and advice to pharmacists on the administration of RSV vaccines.
An expert on RSV vaccination provides insights on barriers that prevent the uptake of RSV vaccines and preventative measure in the pipeline for RSV.
Kristian Hurley, senior vice president of Programs, Advocacy, and Health Equity at Beyond Type 1, discussed the importance of proactive screening for patients with signs of type 1 diabetes (T1D).
Medical professionals describe how pneumococcal disease manifests in adults, detailing its potentially lethal consequences such as sepsis or severe pneumonia, and explain how vaccination can effectively mitigate these serious health risks.
Medical experts outline the key indicators, symptoms, and transmission mechanisms of pneumococcal infections in adult populations.
Because T1D is not necessarily caused by genetics, educating patients about the signs and helping them get tested early is crucial.
Career ladders for pharmacy technicians not only support the staff themselves, but also the broader success of the health system.
Focusing on the preparation of RSV vaccines, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, provides detailed insights on the differences between the adjuvanted and nonadjuvanted vaccines.
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, outlines evidence-based measures that can be implemented to prevent or minimize the transmission of RSV.
Having the authority to prescribe nicotine replacement therapies does not mean that pharmacists are getting involved in these programs, so ongoing research is investigating how to create sustainable models with greater pharmacist involvement.
Tune into this episode of “Public Health Matters” to hear how Walmart is leveraging its network to provide HIV care and specialty pharmacy services and how integrating community pharmacy outreach is significant for patients.
Allison Burns discusses how pharmacists should prepare and educate themselves regarding OTC naloxone, and the steps that can be taken in stores and pharmacies to ensure OTC naloxone is visible and available.
An expert on RSV discusses symptoms that warrant emergent medical care and the overall impact of RSV on older adults or immunocompromised individuals.
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, provides an overview of respiratory syncytial virus (RSV), highlighting disease transmission, incidence, symptoms, and factors that indicate higher risk of hospitalization.
Allison Burns, president and CEO of EMO Health, discusses the price point and stigma surrounding OTC naloxone in an interview with Pharmacy Times.
Alan Chin, PharmD, BCOP, examines the PALOMA-3 trial's influence on the treatment of EGFR-mutated metastatic NSCLC and explores the evolving role of antibody-drug conjugates (ADCs) in the therapeutic landscape of EGFR-mutated NSCLC.
Helping patients overcome barriers to accessing these treatments is a vital role for pharmacists, who can support patients who are looking to quit.
Defined career ladders can highlight that being a technician is not merely a job, but a fulfilling career.
McKesson and state associations are advocating for community pharmacies through initiatives like McKesson Amplify that support advocacy work.
Carrie Koenigsfeld, PharmD, FAPhA, shares strategies that pharmacists can use to effectively tackle vaccine hesitancy, particularly concerning newer vaccines such as the RSV vaccine, through building trust with patients to encourage informed decision-making.
A medical expert examines the ideal timing for administering RSV vaccines to adults over 60 or pregnant women, emphasizing the importance of proper timing for a single-dose vaccine and outlining the necessary steps to be taken if a pregnant woman inadvertently receives an adjuvanted RSV vaccine.
A pharmacy expert explores infusion-related reactions associated with amivantamab, providing guidance on managing and preventing these reactions, while also addressing the role of split-dosing, premedications, and steroids in the treatment paradigm.
Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.
